4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-21-000012
EVP Strategy and Corporate Dev sold 1,079 shares at an average $368.82 ($397,960)
From the SEC's structured data for this filing
Trades in this filing
Pacelli Steven Robert · EVP Strategy and Corporate Dev
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-22 | Sale : show line 1 in the form | −378 | $367.47 | $138,902 | 59,403 | D |
| 2021-01-22 | Sale : show line 2 in the form | −310 | $368.88 | $114,353 | 59,093 | D |
| 2021-01-22 | Sale : show line 3 in the form | −373 | $369.96 | $137,994 | 58,720 | D |
| 2021-01-22 | Sale : show line 4 in the form | −18 | $372.77 | $6,710 | 58,702 | D |
| Open-market sales · 1,079 sh · avg $368.82 · $397,960 | ||||||
Loading xslF345X03/edgardoc.xml…